Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Push Medical Device Technology is a leading Chinese developer of interventional cardiovascular and cerebrovascular medical devices. Its flagship products include left atrial appendage closure systems and congenital heart disease intervention devices. The company has achieved significant regulatory milestones with multiple Class III device approvals in 2022 for its Atrial Septal Puncture System, Left Atrial Guide Wires, and Cardiac Closure Device Delivery System. It holds over 70% market share in key regions of China with strong distribution coverage nationwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Push Medical Device Technology.